
Approximately 10 percent of all medicines found in low- and middle-income countries are either substandard or falsified, ranging from cancer drugs and contraceptives to antibiotics and anti-malarial treatments. And the problem is almost evenly split between patented brand-name drugs and generics, according to new reports from the World Health Organization.
Moreover, the agency maintained there is a tremendous cost – about $30 billion is spent on such medicines.
The same companies that oppose imports also opposed serialization for years, which was to keep the US supply chain safe. Amazingly selective attention … as well as blindness to the falsified meds in the US supply chain already, ‘both domestic and imported.’